IgNS 2025: Supporting Ig Clinicians and Business Professionals

Pre-Conference Seminar

Comprehensive Ig Therapy Overview

The Ig Foundations Pre-Conference Seminar provides a comprehensive annual review and update on immunoglobulin therapy.

Thursday October 16, 2025

Topics covered in this pre-conference seminar include:

  • Updates on products and new indications
  • Clinical use overview
  • Optimizing IVIg and SCIg
  • Mitigating adverse reactions
  • Documentation essentials
  • Staying compliant with updated standards

Pre-Conference Seminar

Essential Industry Pulse-Check

The IgNS Business Forum offers an essential annual business update on the immunoglobulin industry.

Thursday October 16, 2025

Topics covered in this pre-conference seminar include:

  • Key drivers and functions to improve patient outcomes
  • The impact of evolving landscapes and geopolitical shifts
  • Primary factors of business growth
  • Addressing changes in organizational dynamics
  • Strategies and tactics for successful revenue cycle management

Expanded Educational Tracks for Clinicians & Business Professionals
Thursday October 16 - Sunday October 19, 2025

Clinical Practice

Foundations Track

From assessment to disease management series:

  • Complex PI, CIDP, MG, and MS
  • Attaining SCIg competencies
  • Optimizing agency management with strategies for nursing and pharmacy collaboration
  • Bridging the gap with patient assistance programs

Advanced Practice Track

  • Autoimmunity and neuroimmunology
  • The rise of secondary immunodeficiencies
  • Treatment options in the management of complex PI patients
  • The role of adherence in SCIg success
  • Ig and long COVID management
  • FcRN and complement inhibitors in practice

Business Operations

Market Forces

  • Payer dynamics and reimbursement hurdles
  • Revenue cycle management: your Ig practice
  • Key forces shaping the industry: from patients to policy
  • Compliance considerations and pitfalls

Industry Insights

  • Overview of market growth and innovation trends
  • The rise and impact of targeted therapies
  • Supply interruptions: lessons learned

REGISTER NOW